Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wesley Furnback
Estimating the Response and Economic Burden of Rheumatoid Arthritis Patients Treated With Biologic Disease-Modifying Antirheumatic Drugs in Taiwan Using the National Health Insurance Research Database (NHIRD)
PLoS ONE
Multidisciplinary
The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People's Republic of China
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Related publications
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Disease and Economic Burden for Rare Diseases in Taiwan: A Longitudinal Study Using Taiwan’s National Health Insurance Research Database
PLoS ONE
Multidisciplinary
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs
Arthritis Care and Research
Rheumatology
Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Drugs: A Cohort Study
ACR Open Rheumatology
Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
